Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
971.5 DKK | -0.18% |
|
+0.81% | +39.49% |
11:17am | Novo Nordisk's Main Owner Leads $100 Million Financing of Biotech Firm Asceneuron | DJ |
09:00am | Novo owner backs Swiss biotech Asceneuron in $100 million round | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.49% | 631B | |
+63.36% | 856B | |
-4.57% | 359B | |
+17.86% | 325B | |
+8.14% | 297B | |
+5.56% | 234B | |
+16.37% | 226B | |
+14.64% | 177B | |
+1.84% | 165B | |
+2.37% | 126B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- NOVO NORDISK : UBS reaffirms its Sell rating